PE
VYGR icon

Point72 Europe’s Voyager Therapeutics VYGR Stock Holding History

Point72 Europe’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.45K Buy
+525
New +$1.9K ﹤0.01% 651

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Europe's VYGR Position: Q3 2025 in Review

Point72 Europe opened a new position in Voyager Therapeutics (VYGR) in Q3 2025: 525 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #651 among its holdings.

117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Point72 Europe held 525 shares of Voyager Therapeutics worth $2.45K as of Q3 2025.
  • Voyager Therapeutics was a new Point72 Europe position in Q3 2025.
  • Voyager Therapeutics made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #651 holding.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.